Impact of rubella vaccination on elimination of congenital rubella syndrome in Sri Lanka: progress and challenges.

Simple item page
dc.contributor.authorGamage, Deepa
dc.contributor.authorGalagoda, Geethani
dc.contributor.authorPalihawadana, Paba
dc.date.accessioned2016-08-02T09:09:22Z
dc.date.available2016-08-02T09:09:22Z
dc.date.issued2015-07
dc.description.abstractRubella infection in pregnancy can lead to pathologies, including miscarriage, stillbirth and congenital rubella syndrome (CRS) in the neonate. Rubella vaccination can prevent all occurrences of CRS. In Sri Lanka, significant outbreaks of CRS occurred in 1994 and 1995, with 275 and 212 reported cases. In 1996, Sri Lanka introduced rubella vaccination for women aged 16–44 years, to stop CRS. Measles–rubella vaccine was introduced into the routine immunization schedule in 2001 and additional campaigns were carried out in 2003 (all 11–15 year olds) and 2004 (all 16–20 year olds). Reported immunization coverage with a single dose of a rubella-containing vaccine has been more than 95% since 2000. Laboratorysupported surveillance for rubella and CRS was started in 1992. Reported rubella cases fell from 364 (incidence 19/million population) in 1999 to 96 cases (incidence 5/million population) in 2002 and further to 12 cases (incidence 0.6/ million population) in 2014. Laboratory-supported CRS surveillance was started in 1990 and the highest number of CRS cases, 275 (incidence 77/100 000 live births), was diagnosed in 1994. Reported CRS cases fell from 22 cases (incidence 7/100 000 live births) in 2002 to 3 cases (incidence <1/100 000 live births) in 2014. Almost 20 years of routine rubella vaccination has resulted in >96% reduction in reported rubella cases and a corresponding >98% reduction in CRS cases. Despite this great achievement, work remains to eliminate rubella and CRS from Sri Lanka.en_US
dc.identifier.citationWHO South-East Asia Journal of Public Health 2015;4(2): 189-196.en_US
dc.identifier.issn2224-3151
dc.identifier.issn2304-5272
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/176330
dc.language.isoenen_US
dc.publisherWHO Regional Office for South-East Asiaen_US
dc.rightsWHO Regional Office for South-East Asiaen_US
dc.source.urihttps://www.searo.who.int/publications/journals/seajph/issues/seajphv4n2p189.pdfen_US
dc.subjectcongenital rubella syndromeen_US
dc.subjecteliminationen_US
dc.subjectrubella-containing vaccineen_US
dc.subjectrubella vaccinationen_US
dc.subjectSri Lankaen_US
dc.titleImpact of rubella vaccination on elimination of congenital rubella syndrome in Sri Lanka: progress and challenges.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
seajph2015v4n2p189.pdf
Size:
836.59 KB
Format:
Adobe Portable Document Format
Description:
Policy and practice
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
WHO South-East Asia Journal of Public Health